i-SENS, Inc. (KOSDAQ:099190)

Market Cap	574.32B +33.3%
Revenue (ttm)	315.44B +8.3%
Net Income	-5.15B
EPS	-187.00
Shares Out	28.64M
PE Ratio	n/a
Forward PE	717.90
Dividend	100.00 (0.52%)
Ex-Dividend Date	Dec 29, 2025

Volume	87,523
Average Volume	109,698
Open	20,000
Previous Close	20,050
Day's Range	19,630 - 20,300
52-Week Range	12,970 - 27,600
Beta	1.06
RSI	50.71
Earnings Date	May 15, 2026

About i-SENS

i-SENS, Inc. engages in the development, manufacture, and sale of sensors and measuring instruments based on electrochemical and biosensor technologies in South Korea and internationally. The company offers blood glucose monitoring devices; measuring instruments and point-of-care diagnostic devices (POCT), biosensor technologies, diabetes care, acute care, and coagulation care devices; veterinary care devices; and IVD systems. It also provides SmartLog, diabetes management software for mobile and PC. The company was founded in 2000 and is headq...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2000
• Employees: 887
• Stock Exchange: KOSDAQ
• Ticker Symbol: 099190

Financial Performance

In 2025, i-SENS's revenue was 315.44 billion, an increase of 8.35% compared to the previous year's 291.14 billion. Losses were -5.15 billion, 187.0% more than in 2024.